Changlin Mei

12.5k total citations · 3 hit papers
289 papers, 8.5k citations indexed

About

Changlin Mei is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Changlin Mei has authored 289 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 83 papers in Nephrology and 81 papers in Genetics. Recurrent topics in Changlin Mei's work include Genetic and Kidney Cyst Diseases (74 papers), Renal and related cancers (42 papers) and Renal Diseases and Glomerulopathies (33 papers). Changlin Mei is often cited by papers focused on Genetic and Kidney Cyst Diseases (74 papers), Renal and related cancers (42 papers) and Renal Diseases and Glomerulopathies (33 papers). Changlin Mei collaborates with scholars based in China, United States and Hong Kong. Changlin Mei's co-authors include Jinhai Li, Lili Fu, Xiang Gao, Wenxiu Zhang, LV Yue-jin, Xiangchen Gu, Yee Leung, Degang Chen, Bing Dai and Yuhua Qian and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Changlin Mei

281 papers receiving 8.4k citations

Hit Papers

Kruppel-Like Factor 15 Modulates Renal Interstitial Fibro... 2013 2026 2017 2021 2013 2017 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Kruppel-Like Factor 15 Modulates Renal Interstitial Fibrosis by ERK/MAPK and JNK/MAPK Pathways Regulation
    2013 798 citations Xiangchen Gu, Lili Fu et al. profile →
  2. Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
    2017 590 citations Ming Wu, Lili Fu et al. profile →
  3. Feature selection in mixed data: A method using a novel fuzzy rough set-based information entropy
    2016 273 citations Changlin Mei, Jinhai Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changlin Mei China 45 2.4k 1.7k 1.5k 1.4k 1.2k 289 8.5k
Riccardo Bellazzi Italy 46 2.2k 0.9× 264 0.2× 264 0.2× 626 0.4× 1.9k 1.6× 370 8.6k
George Michailidis United States 47 2.8k 1.1× 370 0.2× 168 0.1× 313 0.2× 904 0.8× 257 7.7k
Christopher G. Chute United States 59 5.5k 2.3× 332 0.2× 102 0.1× 1.1k 0.7× 4.8k 4.0× 351 14.9k
Lifeng Wang China 37 4.2k 1.8× 324 0.2× 223 0.1× 441 0.3× 1.5k 1.2× 172 10.0k
Nisha Bansal United States 38 892 0.4× 194 0.1× 1.7k 1.1× 255 0.2× 1.1k 0.9× 164 9.0k
Olga G. Troyanskaya United States 54 11.3k 4.7× 593 0.4× 204 0.1× 2.1k 1.4× 1.3k 1.1× 153 15.8k
Chun Li China 54 4.9k 2.0× 195 0.1× 283 0.2× 1.8k 1.3× 195 0.2× 461 12.8k
Aidong Zhang United States 44 2.1k 0.9× 576 0.3× 128 0.1× 197 0.1× 2.8k 2.3× 377 7.7k
Toshihiko Yanase Japan 44 2.7k 1.1× 260 0.2× 70 0.0× 1.2k 0.8× 979 0.8× 226 9.4k
Ian Graham Ireland 54 1.1k 0.4× 167 0.1× 262 0.2× 363 0.3× 545 0.5× 213 17.0k

Countries citing papers authored by Changlin Mei

Since Specialization
Citations

This map shows the geographic impact of Changlin Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlin Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlin Mei more than expected).

Fields of papers citing papers by Changlin Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changlin Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlin Mei. The network helps show where Changlin Mei may publish in the future.

Co-authorship network of co-authors of Changlin Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Changlin Mei. A scholar is included among the top collaborators of Changlin Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changlin Mei. Changlin Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Changlin, et al.. (2025). A sourceless efficiency calibration model of airborne γ-spectrometry based on Geant4. Nuclear Engineering and Technology. 57(8). 103594–103594.
2.
Kong, Deyang, et al.. (2024). Monocyte/macrophage pyroptosis and C5b-9-induced cyst enlargement in Pkd1−/− mice. Nephrology Dialysis Transplantation. 40(6). 1161–1174. 1 indexed citations
3.
Zhang, Xiao, Yijing Liu, Jinhai Li, & Changlin Mei. (2024). FGRBC: A Novel Fuzzy Granular Rule-Based Classifier Using the Justifiable Granularity Principle and a Fusion Strategy. IEEE Transactions on Fuzzy Systems. 32(12). 7096–7108. 3 indexed citations
4.
Du, Wen, Lili Fu, Yuting Guan, et al.. (2023). Activation of GPER1 in macrophages ameliorates UUO-induced renal fibrosis. Cell Death and Disease. 14(12). 818–818. 9 indexed citations
5.
Ma, Yiyi, Mingzi Zhang, Lili Fu, et al.. (2023). Automatic Segmentation of Kidney Volume Using Multi-Module Hybrid Based U-Shape in Polycystic Kidney Disease. IEEE Access. 11. 58113–58124. 6 indexed citations
6.
Bian, Rongrong, Xuezhen Li, Jing Chen, et al.. (2021). PKD2 gene variants in Chinese patients with autosomal dominant polycystic kidney disease. Clinical Genetics. 100(3). 340–347. 2 indexed citations
7.
Zhang, Zhi, Jing Li, Tung Fung, et al.. (2021). Multiscale geographically and temporally weighted regression with a unilateral temporal weighting scheme and its application in the analysis of spatiotemporal characteristics of house prices in Beijing. International Journal of Geographical Information Systems. 35(11). 2262–2286. 35 indexed citations
8.
9.
Liu, Zhiheng, Xinyi Cao, Yi Lu, et al.. (2019). Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease. Science Advances. 5(6). eaaw3593–eaaw3593. 34 indexed citations
10.
Ge, Xiaofei, Jianlin Lei, Shengqiang Yu, et al.. (2018). Structure of the human PKD1-PKD2 complex. Science. 361(6406). 185 indexed citations
11.
Xue, Cheng, Chenchen Zhou, & Changlin Mei. (2017). Progress of research on network database for polycystic kidney disease. 6(1). 31–33. 1 indexed citations
12.
13.
Yang, Bo, Sixiu Chen, Guang Yang, et al.. (2015). New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol. BMJ Open. 5(11). e008440–e008440. 3 indexed citations
14.
Mei, Changlin, et al.. (2013). Advances in diagnosis and treatment of acute kidney injury. SHILAP Revista de lepidopterología. 38(5). 342–346.
15.
Mei, Changlin. (2013). Clinical Observe Effect of Atorvastatin Combined with Benazepril Treatment of Early Diabetic Nephropathy. 2 indexed citations
16.
Xu, Jing, Chaoyang Ye, Dong‐Ping Chen, et al.. (2012). Immunosuppressive Treatment for Nephrotic Idiopathic Membranous Nephropathy: A Meta-Analysis Based on Chinese Adults. PLoS ONE. 7(9). e44330–e44330. 18 indexed citations
17.
Mei, Changlin. (2011). Vascular access investigation in a hemodialysis center in Shanghai. 1 indexed citations
18.
Mei, Changlin, et al.. (2005). Clinical study of 100 cases with acute renal failure. 1 indexed citations
19.
Song, Jae‐Jun & Changlin Mei. (2003). Effect of keratinocyte growth factor on cell cycle and regulatory protein of cyst-lining epithelia in autosomal dominant polycystic kidney disease.
20.
Ye, Chaoyang, et al.. (2002). High dose of rhEPO in treatment of uremic anemia. 23(11). 1243–1245. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riccardo Bellazzi Breakdown of academic impact, for papers by George Michailidis Breakdown of academic impact, for papers by Christopher G. Chute Breakdown of academic impact, for papers by Lifeng Wang Breakdown of academic impact, for papers by Nisha Bansal Breakdown of academic impact, for papers by Olga G. Troyanskaya Breakdown of academic impact, for papers by Chun Li Breakdown of academic impact, for papers by Aidong Zhang Breakdown of academic impact, for papers by Toshihiko Yanase Breakdown of academic impact, for papers by Ian Graham
Rankless by CCL
2026